How Endometriosis Affects Fertility
Endometriosis impairs fertility primarily through anatomic distortion from invasive growth and adhesions in moderate-to-severe disease (rASRM stages III-IV), while the mechanism remains unclear and controversial in minimal-to-mild disease (stages I-II), where a direct cause-and-effect relationship has not been proven. 1, 2
Mechanisms of Infertility by Disease Severity
Moderate-to-Severe Endometriosis (rASRM III-IV)
The fertility impact is most clearly established in advanced disease through:
- Tubo-ovarian distortion and adhesions that mechanically impair oocyte pickup and embryo transport 3
- Anatomic disruption from invasive endometrial tissue growth 1
- Ovarian endometriomas that reduce oocyte yield (mean difference -1.22 oocytes) and number of mature oocytes (mean difference -2.24) 4
Minimal-to-Mild Endometriosis (rASRM I-II)
The relationship here is far more contentious:
- Controlled trials suggest minimal/mild disease may not directly cause infertility 1
- However, recent evidence shows these milder forms most likely affect fertilization rates (OR 0.77) and implantation rates (OR 0.76) 4
- Peritoneal inflammatory mediators and reactive oxygen species may impair oocyte maturation in animal models, though direct causal evidence in humans is lacking 3
Prevalence and Clinical Impact
Endometriosis affects at least one-third of women with infertility and up to 10% of reproductive-aged women 2. The specific endometriosis typology matters significantly:
- Ovarian endometriomas (OE) and/or deep infiltrating endometriosis (DIE): 2.41-fold higher prevalence of subfertility and 53% lower historic fecundability (aFOR 0.47) 5
- Superficial endometriosis (SE) only: 1.58-fold higher prevalence of subfertility but no significant association with fecundability 5
Reproductive Outcomes
Natural Conception
Women with endometriosis have:
- Reduced live birth ratio confirmed by Mendelian randomization analysis (OR 0.989) 6
- Increased miscarriage risk (OR 1.30) 4
- Fewer children born (1.91 vs 2.26 in controls, p<0.001) 6
Assisted Reproductive Technology (ART)
The impact on IVF outcomes shows important nuances:
- Stages I-II: Live birth rates per cycle are comparable to women without endometriosis 3
- Stages III-IV: Cumulative live birth rates after ≤5 cycles reach 43-46% in treated patients vs 28% in untreated 3
- Most reproducible negative impact: Reduction in number of oocytes retrieved, particularly with endometriomas or after ovarian surgery 7
- Endometrial receptivity: Large registry studies of donor oocyte cycles suggest only marginal impairment, if any 7
Additional Mechanisms Beyond Anatomy
Endometriosis creates a hostile reproductive environment through:
- Persistent inflammation and immune dysregulation 8
- Altered cytokine and chemokine signaling 8
- Progesterone resistance in eutopic endometrium 3
- Impaired decidualization and displaced window of implantation 8
- Epigenetic dysregulation, though its direct causal role in infertility remains unestablished 3
Critical Clinical Caveats
Medical therapy does not improve fertility: Hormonal suppression (progestins, danazol, oral contraceptives, GnRH agonists) reduces lesion size and controls pain but has no evidence of affecting future fertility 1. These medications should never be prescribed with the expectation of improving conception rates.
Surgical outcomes are uncertain: While laparoscopic surgery for stage I-II disease remains debated, and there is no data indicating whether medical or surgical therapy results in better fertility outcomes 1. Cystectomy consistently reduces AMH, favoring IVF over surgery unless symptoms or retrieval barriers exist 3.
Pregnancy complications: Beyond infertility, endometriosis increases risk of preterm delivery (OR 1.38), cesarean section (OR 1.98), and neonatal unit admission (OR 1.29) 4.
Bottom Line
The fertility impact of endometriosis is severity-dependent and mechanism-specific. Advanced disease clearly impairs fertility through anatomic disruption, while minimal disease shows inconsistent effects that may involve inflammatory and molecular pathways rather than mechanical obstruction. Women with any stage of endometriosis and infertility should be considered higher risk and counseled accordingly, with treatment decisions based on disease stage, age, ovarian reserve, and duration of infertility rather than expectation that treating endometriosis will restore fertility 3, 9.